US$ 27.35
wada aod9604 prohibited list 2025 just added tirzepatide (mounjaro) to the 2026 Monitoring Program Frontiers | Illegal and falsified
Description
Health Canada has issued public advisories specifically targeting unauthorized injectable peptide products, and AOD-9604 sits inside that enforcement scope

In laboratory studies, AOD9604 has been shown to promote lipolysis (breakdown of stored fat) in cultured adipocytes (fat cells) and influence the expression of genes related to fat metabolism

The amino acids that are injected into the body stimulate the liver into optimizing the process of metabolism

Injections bypass the gut and correct deficiency

Legal Disclaimer All products on this site are for research and development, laboratory, or analytical use only

Discover how this groundbreaking medication for diabetes is also helping people lose weight
